4th Annual Formulation & Drug Delivery Congress

8 - 9 May 2018, London, United Kingdom


Introduction
Join Oxford Global’s 4th Annual Formulation & Drug Delivery Congress, 8 – 9 May 2018 in London. A new feature of the revamped 2018 agenda is the expansion of the programme to cover advanced drug delivery devices and the areas of bioanalysis & stabilisation. Leading experts will discuss slow delivery devices for antibodies, needle-free delivery systems as well as updates in auto-injectors. The bioanalysis & stabilisation session will look at such areas as bioanalytical development for large molecules, prediction and characterisation of aggregates and particle-size analysis.
Over 350 senior level experts will be attending the 2018 event to network about the latest developments & participate in presentations covering the below main areas: 
  • Large Molecule Drug Formulation
  • Advances in Drug Delivery
  • New to 2018! Drug Delivery Devices
  • Small Molecule Drug Formulation
  • New to 2018! Bioanalysis and Stabilisation
View Agenda:  http://bit.ly/2zFQHzn
FREE LIVE WEBINARS 2018:
Large Molecule Formulation & Drug Delivery
Hosted by Paresh N. Vadgama, Principal Scientist, Glenmark Pharmaceuticals
Register for Free Now: http://bit.ly/2D1gKjd
Nano-based Oncological Drug Delivery
Hosted by Marianne Ashford, Principal Scientist, Drug Targeting, AstraZeneca
& Constantin-C. Coussios, Statutory Chair of Biomedical Engineering, University of Oxford
Register for Free Now: http://bit.ly/2AWUtld
Novel Oral Formulation & Drug Delivery
Hosted by Margaret Landis, Associate Research Fellow, Pfizer
& Dennis Douroumis, Director of Centre for Innovation in Process Engineering and Research, University of Greenwich
Register for Free Now: http://bit.ly/2kLIOP1
For further information please email g.alonso@oxfordglobal.co.uk
Venue
London

London, To be confirmed, London, To be confirmed, United Kingdom

Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*